You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 280 No. 22, December 9, 1998 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (5)
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Related article
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Endocarditis Prophylaxis for Transrectal Prostatic Biopsy

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor.—Transurethral procedures, including cystoscopy, urethral dilation, and transurethral resection of the prostate, have been associated with bacteremia frequencies as high as 17%, 24%, and 31%, respectively.1 For this reason, the American Heart Association (AHA) recommends antibiotic prophylaxis for all patients with high- or moderate-risk cardiac conditions who undergo transurethral procedures.2 On the other hand, the rate of bacteremia associated with gastrointestinal endoscopy is virtually always less than 10%, and mucosal biopsy does not increase this.2 Taking into consideration this rather low frequency of bacteremia associated with gastrointestinal endoscopy, the AHA recommends optional prophylaxis only for patients with high-risk cardiac conditions but not for those with moderate-risk conditions.

However, the AHA recommendations do not address the need for prophylaxis for transrectal prostatic biopsy (TRPB). Although TRPB is performed through the gastrointestinal tract, it is associated with a bacteremia rate reported to be as high as about 70%.3-4 This . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTER

A Close Look at Standards for Therapeutic Touch
Rebecca M. Good, Linda Rosa, Larry Sarner, and Stephen Barrett
JAMA. 1999;282(2):135.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Prevention of Bacterial Endocarditis: Recommendations by the American Heart Association
Adnan S. Dajani, Kathryn A. Taubert, Walter Wilson, Ann F. Bolger, Arnold Bayer, Patricia Ferrieri, Michael H. Gewitz, Stanford T. Shulman, Soraya Nouri, Jane W. Newburger, Cecilia Hutto, Thomas J. Pallasch, Tommy W. Gage, Matthew E. Levison, Georges Peter, and Gregory Zuccaro, Jr
JAMA. 1997;277(22):1794-1801.
ABSTRACT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Guidelines for the prevention of endocarditis: report of the Working Party of the British Society for Antimicrobial Chemotherapy
Gould et al.
J Antimicrob Chemother 2006;57:1035-1042.
ABSTRACT | FULL TEXT  

A Close Look at Standards for Therapeutic Touch
Good et al.
JAMA 1999;282:135-135.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.